FARGO, North Dakota, Sept. 15, 2020 /PRNewswire/ — RxE2 announced today that Lori Doele has joined the company as its new director of business development.
Lori will be responsible for managing RxE2’s partnerships with pharmaceutical and medical device clinical study sponsors.
Following a successful 30-year career in banking, Lori ventured to the clinical research industry in 2011. Over the years she has worked in sales, project management and business development, including as the director of business development –West Coast office at Clinical Supplies Management (CSM), founded by Gerald Finken.
Ms. Doele said, “From my experience at CSM, I personally know the depth and possibilities of Gerald’s vision. CSM is an example of how he built a multi-million business from an idea and changed the way drugs were packaged and delivered. Gerald’s current initiative to make clinical trials available to everyone, everywhere by